Form 8-K - Current report:
SEC Accession No. 0000950170-24-020191
Filing Date
2024-02-26
Accepted
2024-02-26 16:30:15
Documents
12
Period of Report
2024-02-21
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K cmra-20240221.htm   iXBRL 8-K 56454
  Complete submission text file 0000950170-24-020191.txt   205955

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cmra-20240221.xsd EX-101.SCH 55605
13 EXTRACTED XBRL INSTANCE DOCUMENT cmra-20240221_htm.xml XML 4364
Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 (617)871-2101
Comera Life Sciences Holdings, Inc. (Filer) CIK: 0001907685 (see all company filings)

EIN.: 874706968 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41403 | Film No.: 24679383
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)